HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
1 published article · Updated continuously
42 trials tracked for Colonoscopy: 20 in phase 3 or 4 and 3 with published results. The most-cited published study has 301 citations.
Showing the 42 most-cited and recently-updated of 42 trials. Browse the full registry →
Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.
Several bowel preparation regimens have been evaluated for efficacy in colonoscopy. BLI800 demonstrated significant success in bowel cleansing, with a higher percentage of patients achieving successful preparation compared to a control group (p=0.038) 20. BLI4700 also showed significant results in successful bowel cleansing across multiple trials [11, 15, 21, 22]. Other preparations, including PEG-3350 based regimens 13, PEG-ELS 16, and PICOPREP 18, were also evaluated for successful bowel cleansing or completion of the colonoscopy examination.
Lubiprostone was shown to improve endoscopist evaluation of colon cleanliness compared to placebo (p=0.05) and significantly improved the tolerability of the colon cleansing regimen (p=<0.05) while reducing the required volume of PEG 2. The SUPREP Bowel Prep Kit showed a 95% success rate for 'good' or 'excellent' preparation 6. Additionally, a PEG electrolyte lavage solution with bisacodyl reformulation showed a statistically significant improvement in successful preparations (p=0.005) 9.
Sedation and procedural management trials indicate that Remimazolam significantly improved procedure success rates and reduced the time to start of the procedure (p=<0.0001) 10. The use of a Computer-Assisted Personalized Sedation (CAPS) device was associated with higher clinician satisfaction compared to standard methods (p=<0.001) 19. Other pharmacological interventions included Diphenhydramine for pain and amnesia scores 4, Dexmedetomidine for discharge readiness 5, and Remifentanil for discharge time 8.
AI synthesis of 12 cited trials, updated Sep 12, 2026. Informational only — not medical advice; trial data sourced from ClinicalTrials.gov. How we use AI.